BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38358521)

  • 1. Salvage vesiculectomy for local prostate cancer recurrence: surgical technique and early post-operative outcomes.
    Giesen A; Van den Broeck T; Develtere D; Raskin Y; Wymer K; Eden C; Claessens M; Hente R; Rans K; Berghen C; De Meerleer G; Langley S; Karnes RJ; Heidenreich A; Pfister D; Joniau S
    World J Urol; 2024 Feb; 42(1):81. PubMed ID: 38358521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robot-assisted salvage seminal vesicle excision for isolated recurrence after low-dose-rate prostate brachytherapy.
    Langley S; Eden C; Perry M; Patil K; Moschonas D; Higgins D; Deering C; Laing R; Perna C; Khaksar S; Uribe-Lewis S; Uribe J
    BJU Int; 2022 Jun; 129(6):731-736. PubMed ID: 34460980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy.
    Knipper S; Ascalone L; Ziegler B; Hohenhorst JL; Simon R; Berliner C; van Leeuwen FWB; van der Poel H; Giesel F; Graefen M; Eiber M; Heck MM; Horn T; Maurer T
    Eur Urol; 2021 Apr; 79(4):537-544. PubMed ID: 33317857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage Cryoablation and Robotic Seminal Vesiculectomy: A Novel Salvage Treatment for Locally Recurrent Prostate Cancer.
    Smigelski MB; Wysock J; Taneja SS; Lepor H
    J Endourol; 2023 Aug; 37(8):876-881. PubMed ID: 37300480
    [No Abstract]   [Full Text] [Related]  

  • 5. Value of
    Rauscher I; Düwel C; Wirtz M; Schottelius M; Wester HJ; Schwamborn K; Haller B; Schwaiger M; Gschwend JE; Eiber M; Maurer T
    BJU Int; 2017 Jul; 120(1):40-47. PubMed ID: 27862863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial multicentre experience of
    Siriwardana A; Thompson J; van Leeuwen PJ; Doig S; Kalsbeek A; Emmett L; Delprado W; Wong D; Samaratunga H; Haynes AM; Coughlin G; Stricker P
    BJU Int; 2017 Nov; 120(5):673-681. PubMed ID: 28548372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robot-assisted Prostate-specific Membrane Antigen-radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study.
    de Barros HA; van Oosterom MN; Donswijk ML; Hendrikx JJMA; Vis AN; Maurer T; van Leeuwen FWB; van der Poel HG; van Leeuwen PJ
    Eur Urol; 2022 Jul; 82(1):97-105. PubMed ID: 35339318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results].
    Vidmar R; Marcq G; Flamand V; Fantoni JC; Hénon F; Villers A; Ouzzane A
    Prog Urol; 2017; 27(8-9):458-466. PubMed ID: 28576424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-operative, functional and early oncologic outcomes of salvage robotic-assisted radical prostatectomy after high-intensity focused ultrasound partial ablation.
    Thompson JE; Sridhar AN; Shaw G; Rajan P; Mohammed A; Briggs TP; Nathan S; Kelly JD; Sooriakumaran P
    BMC Urol; 2020 Jul; 20(1):81. PubMed ID: 32611411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological outcome of patients treated with spot-specific salvage lymphnode dissection (sLND) for positron-emission tomography (PET)-positive prostate cancer (PCa) relapse.
    Hiester A; Nini A; Niegisch G; Arsov C; Hautzel H; Antke C; Schimmöller L; Albers P; Rabenalt R
    World J Urol; 2019 Oct; 37(10):2081-2090. PubMed ID: 30643974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery.
    Knipper S; Mehdi Irai M; Simon R; Koehler D; Rauscher I; Eiber M; van Leeuwen FWB; van Leeuwen P; de Barros H; van der Poel H; Budäus L; Steuber T; Graefen M; Tennstedt P; Heck MM; Horn T; Maurer T
    Eur Urol; 2023 Jan; 83(1):62-69. PubMed ID: 35718637
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Maurer T; Robu S; Schottelius M; Schwamborn K; Rauscher I; van den Berg NS; van Leeuwen FWB; Haller B; Horn T; Heck MM; Gschwend JE; Schwaiger M; Wester HJ; Eiber M
    Eur Urol; 2019 Apr; 75(4):659-666. PubMed ID: 29625755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and Oncologic Outcome of Salvage Surgery in Isolated Seminal Vesicle Remnants after Radical Prostatectomy.
    Pfister D; Nestler T; Hartmann F; Haidl F; Pullankavumkal J; Schmidt M; Heidenreich A
    Urol Int; 2022; 106(1):44-50. PubMed ID: 33827096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trial.
    Blazevski A; Geboers B; Scheltema MJ; Gondoputro W; Doan P; Katelaris A; Agrawal S; Baretto D; Matthews J; Haynes AM; Delprado W; Shnier R; van den Bos W; Thompson JE; Lawrentschuk N; Stricker PD
    BJU Int; 2023 Jun; 131 Suppl 4():23-31. PubMed ID: 36495482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
    Falkenbach F; Knipper S; Koehler D; Ambrosini F; Steuber T; Graefen M; Budäus L; Eiber M; Lunger L; Lischewski F; Heck MM; Maurer T
    World J Urol; 2023 Sep; 41(9):2343-2350. PubMed ID: 37515651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.
    Qaoud Y; Herrera-Caceres JO; Bass R; Berjaoui MB; Tiwari R; Kenk M; Lajkosz K; Finelli A; Perlis N; Klotz L; Fleshner N
    Urol Oncol; 2022 Jul; 40(7):343.e1-343.e6. PubMed ID: 35537905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
    Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
    Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological and Functional Outcomes for Men Undergoing Salvage Whole-gland Cryoablation for Radiation-resistant Prostate Cancer.
    Tan WP; Kotamarti S; Ayala A; Mahle R; Chen E; Arcot R; Chang A; Michael Z; Seguier D; Polascik TJ
    Eur Urol Oncol; 2023 Jun; 6(3):289-294. PubMed ID: 36890104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.